WELLBUTRIN (BUPROPION HYDROCHLORIDE) — FDA Approval NDA018644 (GLAXOSMITHKLINE)
WELLBUTRIN (BUPROPION HYDROCHLORIDE) — FDA Approval NDA018644 (GLAXOSMITHKLINE) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: WELLBUTRIN; Active ingredients: BUPROPION HYDROCHLORIDE; Application number: NDA018644.
| Brand name | WELLBUTRIN |
|---|---|
| Active ingredients | BUPROPION HYDROCHLORIDE |
| Application number | NDA018644 |
| Sponsor | GLAXOSMITHKLINE |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 3 |
| First approval date | 19851230 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →